I really feel from all my readings into the 10k and the
I really feel from all my readings into the 10k and the 9/24 8k’s that we should expect some sort of news next week. It could be as soon as Monday morning and will probably give us a clear understanding of all items we wonder about moving forward.
Timeline of events:
Milestone agreement with Aspire- this cost management $2 million to obtain $2 million with incentive of another $5 million with milestones. This was done to give IPIX financial footing when negotiating a term sheet.
10k shows the $2 million commitment fee as a loss- sometime in the summer management knew the term sheet would be signed and Aspire would no longer be needed. They issues the 10k to show the financial loss and to utilize material information to state they are unlikely to hit milestones and that a term sheet had been signed. They also stated that P results had not been received by that time. It does not mean P results haven’t be received from 10k to now.
Dr. Menon is terminated- very telling to the situation
Dr. B and Jane Harness accelerate their 2016 incentive shares- the most telling of everything in this timeline.
Manipulation to drive price down to all new lows, hit stop losses and create volume to acquire cheaply.
My OVERALL prediction *** Buy-Out *** at least 50% of the common shares to be acquired through buy-out or controlling partnership. I feel we had term sheet for B-OM added with B-IBD but the kicker was P results. I have a feeling P results are under the NDA and may be known. They may not be fully known but the other company wants P anyway for their own reasons.
We shall see...
8
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Understanding the Investor Landscape The landscape of investor rights is evolving, and in the case of iLearningEngines, Inc., investors find themselves at a significant crossroads. The company, which trades on NASDAQ under the ticker AILE, is currently facing a class action lawsuit led by a dedicated group of investors and the Schall Law Firm. The Class Action Against...
Continue Reading
EditForce's Groundbreaking Research on Myotonic Dystrophy EditForce, Inc. has announced a pivotal breakthrough in the treatment of Myotonic Dystrophy Type 1, significantly enhancing the future of therapeutic options for this challenging condition. The research highlights the efficacy of their innovative PPR platform technology, specifically the CUG-PPR1 protein that...
Continue Reading
The Return of dancemoon MoonRoller and New Layer Brush Mini dancemoon, a pioneer in innovative home cleaning solutions, has officially re-launched its popular flagship product, the dancemoon MoonRoller, alongside the new Layer Brush Mini. This latest offering is now available for purchase globally through the brand's official website and other major e-commerce platforms....
Continue Reading
Carriage Services Announces Earnings Release for Q3 2024 HOUSTON, Carriage Services, Inc. (NYSE: CSV) is set to unveil its third quarter earnings results for 2024. The earnings report is scheduled for release on Wednesday, following the market's closing bell, signaling a vital moment for shareholders and the market at large. Investors are keenly awaiting the insights that...
Continue Reading
Spanish Market Overview The Spanish stock market showed positive momentum recently, with the IBEX 35 index recording a modest gain of 0.19%. This uptick reflects a notable shift in investor sentiment across various sectors, leading to an overall increase in share prices. Leading Sectors Driving Growth The rise in the IBEX 35 was attributed primarily to strong performances...
Continue Reading